As platelet-rich plasma (PRP) contains large numbers of growth factors and has been widely used for tissue regeneration, this study aimed to study PRP as an adjuvant to enhance composite graft survival.
The use of extracorporeal membrane oxygenation (ECMO) in children after cardiac surgery is well established. ECMO support is becoming an integral tool for cardiopulmonary resuscitation in specified centers.
Results of the PARTNER (Placement of AoRTic TraNscathetER Valve) trial comparing the clinical effectiveness of TAVI with surgical valve replacement and standard therapy were published.